APG Asset Management N.V. bought a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 155,300 shares of the company’s stock, valued at approximately $9,548,000. APG Asset Management N.V. owned about 0.29% of Nu Skin Enterprises at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. US Bancorp DE boosted its stake in shares of Nu Skin Enterprises by 3.3% during the 2nd quarter. US Bancorp DE now owns 2,032 shares of the company’s stock valued at $128,000 after buying an additional 65 shares during the last quarter. Independent Portfolio Consultants Inc. boosted its stake in shares of Nu Skin Enterprises by 14.9% during the 2nd quarter. Independent Portfolio Consultants Inc. now owns 2,730 shares of the company’s stock valued at $172,000 after buying an additional 355 shares during the last quarter. CENTRAL TRUST Co purchased a new position in shares of Nu Skin Enterprises during the 2nd quarter valued at approximately $187,000. Pillar Pacific Capital Management LLC purchased a new position in shares of Nu Skin Enterprises during the 2nd quarter valued at approximately $202,000. Finally, Ronald Blue & Co. LLC purchased a new position in shares of Nu Skin Enterprises during the 2nd quarter valued at approximately $207,000. Institutional investors own 79.74% of the company’s stock.
Several research firms have recently commented on NUS. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a research note on Wednesday, August 2nd. BidaskClub cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Bank of America Corporation increased their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research note on Monday, July 10th. Zacks Investment Research upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a research note on Wednesday, July 12th. Finally, Stifel Nicolaus set a $50.00 target price on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Thursday, August 3rd. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company’s stock. Nu Skin Enterprises currently has an average rating of “Hold” and a consensus price target of $62.00.
WARNING: This article was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/11/03/155300-shares-in-nu-skin-enterprises-inc-nus-purchased-by-apg-asset-management-n-v.html.
Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.76. Nu Skin Enterprises had a return on equity of 22.66% and a net margin of 6.97%. The company had revenue of $563.70 million for the quarter, compared to analyst estimates of $562.70 million. During the same quarter last year, the firm earned $0.98 EPS. Nu Skin Enterprises’s revenue for the quarter was down 6.7% compared to the same quarter last year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.37%. The ex-dividend date of this dividend is Thursday, November 16th. Nu Skin Enterprises’s payout ratio is presently 52.75%.
In other news, President Ryan S. Napierski sold 6,933 shares of Nu Skin Enterprises stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $64.00, for a total transaction of $443,712.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Daniel W. Campbell sold 4,607 shares of Nu Skin Enterprises stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $62.48, for a total value of $287,845.36. Following the sale, the director now directly owns 63,753 shares in the company, valued at approximately $3,983,287.44. The disclosure for this sale can be found here. Insiders have sold a total of 19,040 shares of company stock worth $1,188,157 in the last three months. 5.20% of the stock is owned by insiders.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
What are top analysts saying about Nu Skin Enterprises Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Nu Skin Enterprises Inc. and related companies.